Nobilis Therapeutics leadership will be attending J.P.Morgan’s 36th Annual Healthcare Conference that will take place in San Francisco on January 8-11. If you are interested in setting up a f2f meeting with our team, please send us an email.
News
- Nobilis Therapeutics just published an article “Xenon as Promising Treatment for Patients with PTSD: Case Report, Justification of Approach and Review of Literature” in Annals of Psychiatry and Mental Health November 28, 2018
- US Patent Granted for Nobilis Therapeutics Invention Covering Treatments of Rheumatologic Disorders With Noble Gases August 1, 2018
- Nobilis Therapeutics Adds Three World-Renowned PTSD Experts to Scientific Advisory Board June 1, 2018
- Nobilis Therapeutics will participate in BIO International Convention in Boston, MA on June 4-7, 2018 May 18, 2018
- Nobilis Therapeutics issues a press release after a productive meeting with the House of Representatives Committee on Veterans’ Affairs. February 23, 2018
Recent Posts
- Nobilis Therapeutics just published an article “Xenon as Promising Treatment for Patients with PTSD: Case Report, Justification of Approach and Review of Literature” in Annals of Psychiatry and Mental Health
- US Patent Granted for Nobilis Therapeutics Invention Covering Treatments of Rheumatologic Disorders With Noble Gases
- Nobilis Therapeutics Adds Three World-Renowned PTSD Experts to Scientific Advisory Board
- Nobilis Therapeutics will participate in BIO International Convention in Boston, MA on June 4-7, 2018
- Nobilis Therapeutics issues a press release after a productive meeting with the House of Representatives Committee on Veterans’ Affairs.
Recent Comments